A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D. Asselah T, Chattergoon MA, Jucov A, Streinu-Cercel A, et al. N Engl J Med 2025 Nov 9. doi: 10.1056/NEJMoa2508827.

Read + Share

Amedeo Smart

Independent Medical Education

Asselah T, Chattergoon MA, Jucov A, Streinu-Cercel A, et al. A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D. N Engl J Med 2025 Nov 9. doi: 10.1056/NEJMoa2508827.
PMID: 41211943